2026 NPPES data Neuromuscular Medicine (Psychiatry & Neurology) Physician NPI 1366837734 MD, MPH
Verify on CMS →

MARK TERRELONGE, MD, MPH

Neuromuscular Medicine (Psychiatry & Neurology) Physician in SAN FRANCISCO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
332
Medicare Part D claims · 57 beneficiaries · Neuromuscular Medicine (Psychiatry & Neurology) Physician avg: 931
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.8508/100
▲ 9 pts above national avg 83.1 · [object Object]
What the federal data reveals: MARK TERRELONGE, MD, MPH is a Neuromuscular Medicine (Psychiatry & Neurology) Physician ([object Object]) practicing in SAN FRANCISCO, California with a Medicare Part D prescribing footprint of 332 claims across 57 beneficiaries — 21% brand-name prescribing . Their CMS MIPS Final Score of 91.8508/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: MARK TERRELONGE, MD, MPH reported a CMS MIPS final score of 91.8508 out of 100, above the 83.1 national average, and filed 332 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK TERRELONGE, MD, MPH practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK TERRELONGE, MD, MPH at a glance

High performer (top quartile)

NPI registry status

Active

Issued 04/02/2015

NPI 1366837734

Primary specialty

Neuromuscular Medicine (Psychiatry & Neurology) Physician

Rare

336 US NPIs in this specialty

Medicare Part D claims

332 64% vs specialty avg

2023 prescription claims

Specialty avg: 931

MIPS final score

91.8508/100 8.750800000000012% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Neuromuscular Medicine (Psychiatry & Neurology) Physician compares to other specialties among California providers

California providers

Neuromuscular Medicine (Psychiatry & Neurology) Physician share within California

1. Neuromuscular Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuromuscular Medicine (Psychiatry & Neurology) Physician share within California

Medicare quality performance — MIPS

MARK TERRELONGE, MD, MPH's 2023 MIPS final score plotted against the Neuromuscular Medicine (Psychiatry & Neurology) Physician national average

High performer (top quartile)
MIPS Final Score
91.8508/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) — 91.8508/100 vs national avg 83.1

0%100%National avg83%91.9%
MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) — 91.8508/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK TERRELONGE, MD, MPH is a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider practicing in SAN FRANCISCO, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, MPH. NPI: 1366837734. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK TERRELONGE, MD, MPH appears in the CMS NPPES registry as a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider holding MD, MPH credentials at 505 PARNASSUS AVE, SAN FRANCISCO, CA, 94143, with a listed phone of (415) 476-3891. NPI 1366837734 was issued on 04/02/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TERRELONGE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 332 prescription claims written by this provider, covering 57 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 21% brand-name and 79% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.8508/100 for the 2023 performance year (Quality 83.5371, Cost 68.0152), compared with the national average of 83.1.

Neuromuscular Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 336 enrolled providers across 44 states and an average of 931 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

505 PARNASSUS AVE
SAN FRANCISCO, CA 94143

Provider Details

NPI 1366837734
Specialty Neuromuscular Medicine (Psychiatry & Neurology) Physician
Credentials MD, MPH
Gender Male
NPI Issued 04/02/2015

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.8508
Final Score
Avg: 83.1
83.5371
Quality
68.0152
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK TERRELONGE, MD, MPH bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UCSF MEDICAL GROUP BUSINESS SERVICES
SAN FRANCISCO, CA
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
SAN FRANCISCO, CA
UNIVERSITY OF CALIFORNIA SFGH MEDICAL GROUP
SAN FRANCISCO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARK TERRELONGE, MD, MPH. To verify MARK TERRELONGE, MD, MPH's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK TERRELONGE, MD, MPH — brand share 21.0%
Specialty average (est.)

21% brand-name claims vs 79% generic, on 332 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

332
Total Claims
$1.0M
Total Drug Cost
57
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
494
Total Day Supply
14,405
Brand vs Generic
21% brand / 79% generic
Brand Drug Cost
$1.0M
Generic Drug Cost
$24K

Patient Demographics

Average Patient Age
71.9 years
Avg HCC Risk Score
1.53
Gender Split
56% female / 44% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Gabapentin
36
Pregabalin
31
Riluzole
26
Duloxetine Hcl
23
Prednisone
19
Radicava Ors
Edaravone
18
Baclofen
17
Relyvrio
Sod Phenylbutyrat/Taurursodiol
17
Pyridostigmine Bromide
15
Diazepam
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuromuscular Medicine (Psychiatry & Neurology) Physician Overview

How MARK TERRELONGE, MD, MPH fits within the Neuromuscular Medicine (Psychiatry & Neurology) Physician landscape nationally.

336
Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in US
44
States with Neuromuscular Medicine (Psychiatry & Neurology) Physician
931
Avg Claims per Provider

MARK TERRELONGE, MD, MPH's 332 claims are below the specialty average of 931.

Nearby Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as TERRELONGE.

Compare Neuromuscular Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK TERRELONGE, MD, MPH's specialty?
MARK TERRELONGE, MD, MPH specializes in Neuromuscular Medicine (Psychiatry & Neurology) Physician and practices in SAN FRANCISCO, California. Credentials: MD, MPH.
How much does MARK TERRELONGE, MD, MPH prescribe under Medicare Part D?
In 2023, MARK TERRELONGE, MD, MPH wrote 332 Medicare Part D claims totaling $1.0M in drug costs for 57 beneficiaries.
What is MARK TERRELONGE, MD, MPH's Medicare quality score?
MARK TERRELONGE, MD, MPH has a CMS MIPS Final Score of 91.8508/100 (Quality: 83.5371, Cost: 68.0152). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK TERRELONGE, MD, MPH located?
MARK TERRELONGE, MD, MPH is located at 505 PARNASSUS AVE, SAN FRANCISCO, CA, 94143. Phone: (415) 476-3891.
What is MARK TERRELONGE, MD, MPH's NPI number?
MARK TERRELONGE, MD, MPH's National Provider Identifier (NPI) is 1366837734, issued on 04/02/2015.
Does MARK TERRELONGE, MD, MPH prescribe more brand-name or generic drugs?
MARK TERRELONGE, MD, MPH's prescribing is 21% brand-name and 79% generic drugs by claim count, with $1.0M in brand drug costs.
How many Neuromuscular Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 336 Neuromuscular Medicine (Psychiatry & Neurology) Physician providers across 44 states in the US. The average Neuromuscular Medicine (Psychiatry & Neurology) Physician provider writes 931 Medicare Part D claims per year.
What drugs does MARK TERRELONGE, MD, MPH prescribe most often?
Based on 2023 Medicare Part D data, MARK TERRELONGE, MD, MPH's most frequently prescribed drugs include Gabapentin, Pregabalin, Riluzole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK TERRELONGE, MD, MPH accept Medicare?
MARK TERRELONGE, MD, MPH appears in CMS Medicare data with 332 Part D claims and 57 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK TERRELONGE, MD, MPH's credentials?
MARK TERRELONGE, MD, MPH's NPI is 1366837734 with credentials MD, MPH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology